The quality of sleep in patients with heart surgery.
Conditions
Interventions
Intervention 1: Interventions in the complement or intervention group are 35 patients who will receive 530 mg capsules of valerian capsules from the second day after surgery every night for one month.
Treatment - Drugs
Interventions in the complement or intervention group are 35 patients who will receive 530 mg capsules of valerian capsules from the second day after surgery every night for one month
In the placebo or control group, 35 patients and the like, placebo will receive capsules containing wheat flour orally
Sponsors
Vice chancellor for research Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : Non-emergency open-heart surgery?age group 40-80 years old? first heart surgery? routine operation in the operating room? use of foot saphenous vein and left internal mammary artery? Post ICU post-operative second day? Alert? lacking Tracheal tube? Understanding the content in Farsi? lack of history of seizure and psychiatric disorders?lack of drug and alcohol? lack of intra-aortic pump?no sleep disorders known prior to admission? EF more than 30%? Patient's satisfaction to participate in the research? Use of the heart and lung pump ?no history of lung, kidney and liver failure? normal creatinine?no use of herbal medicines Effects on sleeping? not taking hypnotic drugs and antidepressants 3 months before the start of the study? lack of allergy to valerian and other herbal remedies with sedation such as chamomile? lavender and, etc.? lack of pregnancy at the beginning of the study? blood pressure of more than 100 mmHg . Exit criteria: The complications of surgery during the study? the need for intra-aortic pump? the reluctance to continue to participate in the research? the lack of drug for one week? allergy to valerian in the study time, pregnancy at the time of study? the existence of individual and family crises such as divorce Or the death of the first degree relatives during the study period?the patient's death? severe insomnia? coagulation disorder during the admission? the occurrence of cognitive impairment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep. Timepoint: Pre-intervention - 3, 14 and 30 days later intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHalimeh Khaton Zare Elmi
Lorestan University of Medical Sciences
Outcome results
None listed